Antharis Therapeutics, Inc.

At Antharis Therapeutics, Inc. we believe raising awareness is key to supporting those impacted by cancer and driving positive change in healthcare. This March, we join millions in recognizing Colorectal Cancer Awareness Month, Kidney Cancer Awareness Month, and Multiple Myeloma Awareness Month — three critical causes at the heart of our mission. We are proud to be directly advancing treatments for these cancers through our innovative biotherapeutic programs, working to improve outcomes and support patients on their journey. Early detection and education are powerful tools in the fight against cancer. By supporting awareness efforts and fostering conversations, we can help break down stigmas, promote screenings, and encourage access to life-saving resources. To everyone affected by these cancers — patients, survivors, families, and caregivers — we honor your strength and resilience. Let’s continue working together toward a future where innovation, compassion, and community lead the way. #Antharis #monoclonalantibodies #ADC, #colorectalcancerawareness #kidneycancerAwareness #multiplemyelomaawareness

Today, on World Cancer Day, we stand with those affected by cancer and the professionals dedicated to advancing care. This year’s theme, “United by Unique,” highlights the power of collective action while recognizing the unique challenges and contributions of individuals in the fight against cancer. At Antharis Therapeutics, Inc. we are dedicated to this fight through groundbreaking research, pioneering innovative therapies, and accelerating treatment development. By uniting our unique strengths, we strive to drive progress and bring hope to those affected by cancer. To those battling cancer, you are not alone. To the researchers and caregivers, we thank you. #worldcancerday #unitedbyunique #antharis #cancer #oncology #monoclonalantibodies #ADC

At Antharis Therapeutics, Inc. we believe in the power of knowledge, support, and innovation to make a difference in the fight against cancer. As we recognize Cancer Awareness Month, we stand in solidarity with those affected - patients, survivors, families, caregivers, and medical professionals - who show incredible resilience every day. Cancer touches so many lives, and early detection, research, and access to care are crucial in improving outcomes. That is why we encourage open conversations, regular screenings, and support for organizations leading the charge in cancer prevention and treatment. Together, we can spread awareness, support those in need, and move closer to a future where cancer no longer takes so much from so many. Join us in sharing resources, uplifting stories, and advocating for a healthier world. If you or someone you know has been impacted, know that you are not alone - Antharis stands with you. #cancerawarenessmonth #hope #support #anthariscares #cancer #monoclonalantibodies #biotherapeutics

We are thrilled to announce that Antharis Therapeutics, Inc. has been named “Antibodies Development Company of the Year 2025”, by Life Sciences Review. This incredible recognition is particularly meaningful to us because it reflects the votes and trust of industry peers, c-level executives from leading pharmaceutical companies, and from LSR’s subscriber base. It is a testament to the hard work, expertise, and passion of our entire team, as well as the trust our partners place in our ability to innovate and deliver in the antibody therapeutics space. A heartfelt thank you to everyone who voted for us and to our outstanding team for making this possible. #innovation #leadership #antibodytherapeutics #ADC #cancer #oncology

A message from our CEO & Chairman, Dr. Raphael Ribeiro-Pinaud: This Thanksgiving, I want to express my deepest gratitude for the incredible team at Antharis Therapeutics, Inc. and the shared purpose that drives us to push the boundaries of science and innovation, advancing therapies that have the potential to transform lives. Every breakthrough we pursue is fueled by our vision to bring optimism to patients and families affected by serious illness, and is made possible by the dedication and resilience of our exceptional group. I am humbled by the commitment and passion of everyone working toward a future where science brings hope to those who need it most. I also want to thank our partners, collaborators, and the patients who inspire us to aim higher every day. As I reflect on the progress we have made to date, and the impact and challenges ahead, I am reminded of the power of collective purpose. Wishing you and your loved ones a joyful and meaningful Thanksgiving, filled with gratitude, connection, and hope for the future.